Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
25.26
+0.81 (3.31%)
At close: Mar 28, 2024, 4:00 PM
25.47
+0.21 (0.83%)
After-hours: Mar 28, 2024, 5:29 PM EDT

Akero Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
234.21249.77150.48187.2464.7975.980.62
Short-Term Investments
315.8101.6837.7881.1571.6100
Cash & Cash Equivalents
550.01351.45188.26268.39136.475.980.62
Cash Growth
56.50%86.68%-29.86%96.76%79.53%12193.69%-
Other Current Assets
9.953.725.322.961.651.160.02
Total Current Assets
559.96355.17193.58271.35138.0577.130.64
Property, Plant & Equipment
1.031.291.551.79000
Long-Term Investments
19.28000000
Other Long-Term Assets
00.110.420.20.070.020.02
Total Long-Term Assets
20.311.41.971.990.070.020.02
Total Assets
580.27356.57195.55273.34138.1277.150.66
Accounts Payable
7.047.976.713.430.951.370.06
Other Current Liabilities
12.0911.1218.429.688.420.970.16
Total Current Liabilities
19.1319.0825.1313.119.372.340.22
Long-Term Debt
25.7810.621.311.52000
Other Long-Term Liabilities
0.050.31000.0205
Total Long-Term Liabilities
25.8410.931.311.520.0205
Total Liabilities
44.9730.0126.4414.639.392.345.22
Total Debt
25.7810.621.311.52000
Debt Growth
142.78%710.07%-13.52%----
Retained Earnings
-574.1-422.34-310.3-209.53-130.32-86.57-4.56
Comprehensive Income
0.270.04-0.03-0-0.0100
Shareholders' Equity
535.31326.56169.11258.71128.73-49.92-4.56
Net Cash / Debt
524.23340.83186.95266.87136.475.980.62
Net Cash / Debt Growth
53.81%82.31%-29.95%95.65%79.53%12193.69%-
Net Cash Per Share
9.978.745.378.489.05734.75-
Working Capital
540.83336.09168.45258.23128.6874.790.42
Book Value Per Share
10.188.384.868.228.54-482.76-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).